Abstract
While extra-articular ligaments such as the medial collateral ligament (MCL) benefit from the absence of adverse effects from synovial fluid and therefore rarely encounter issues of healing absent of intervention, intra-articular ligament injuries, for instance an anterior cruciate ligament (ACL) tear, requires biological intervention to assist with native healing due to a lack of intrinsic healing potential. To enhance healing capacities, different types of biologics such as growth factors and stem cells can be applied. The intended goals for the use of biologics in ligament injuries are primarily geared toward accelerating healing while minimizing the risk of a reinjury. While the results of preclinical and basic science studies are promising, to date there is insufficient evidence to suggest that the use of biologics provides any significant clinical benefit.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Centeno CJ, Pitts J, Al-Sayegh H, et al. Anterior cruciate ligament tears treated with percutaneous injection of autologous bone marrow nucleated cells: a case series. J Pain Res. 2015;8:437–47.
Chahla J, Cinque ME, Piuzzi NS, et al. A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am. 2017;99:1769–79.
Chahla J, Mannava S, Cinque ME, et al. Bone marrow aspirate concentrate harvesting and processing technique. Arthrosc Tech. 2017;6:e441–5.
Cheng M, Johnson VM, Murray MM. Effects of age and platelet-rich plasma on ACL cell viability and collagen gene expression. J Orthop Res. 2012;30:79–85.
Cheng MT, Liu CL, Chen TH, et al. Comparison of potentials between stem cells isolated from human anterior cruciate ligament and bone marrow for ligament tissue engineering. Tissue Eng Part A. 2010;16:2237–53.
Cinque ME, Dornan GJ, Chahla J, et al. High rates of osteoarthritis develop after anterior cruciate ligament surgery: an analysis of 4108 patients. Am J Sports Med. 2017;46(8):2011–9. https://doi.org/10.1177/0363546517730072.
Dallo I, Chahla J, Mitchell JJ, et al. Biologic approaches for the treatment of partial tears of the anterior cruciate ligament: a current concepts review. Orthop J Sports Med. 2017;5:2325967116681724.
Figueroa D, Figueroa F, Calvo R, et al. Platelet-rich plasma use in anterior cruciate ligament surgery: systematic review of the literature. Arthroscopy. 2015;31:981–8.
Frobell RB, Lohmander LS, Roos HP. Acute rotational trauma to the knee: poor agreement between clinical assessment and magnetic resonance imaging findings. Scand J Med Sci Sports. 2007;17:109–14.
Kanaya A, Deie M, Adachi N, et al. Intra-articular injection of mesenchymal stromal cells in partially torn anterior cruciate ligaments in a rat model. Arthroscopy. 2007;23:610–7.
Laprade RF, Dragoo JL, Koh JL, et al. AAOS research symposium updates and consensus: biologic treatment of orthopaedic injuries. J Am Acad Orthop Surg. 2016;24:e62–78.
Laprade RF, Geeslin AG, Murray IR, et al. Biologic treatments for sports injuries II think tank-current concepts, future research, and barriers to advancement, part 1: biologics overview, ligament injury, tendinopathy. Am J Sports Med. 2016;44:3270–83.
Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science. 2010;328:562–4.
Li H, Hicks JJ, Wang L, et al. Customized platelet-rich plasma with transforming growth factor beta1 neutralization antibody to reduce fibrosis in skeletal muscle. Biomaterials. 2016;87:147–56.
Moatshe G, Morris ER, Cinque ME, et al. Biological treatment of the knee with platelet-rich plasma or bone marrow aspirate concentrates. Acta Orthop. 2017;88:670–4.
Murray IR, Geeslin AG, Goudie EB, et al. Minimum information for studies evaluating biologics in orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells. J Bone Joint Surg Am. 2017;99:809–19.
Murray MM, Fleming BC. Biology of anterior cruciate ligament injury and repair: kappa delta ann doner Vaughn award paper 2013. J Orthop Res. 2013;31:1501–6.
Murray MM, Palmer M, Abreu E, et al. Platelet-rich plasma alone is not sufficient to enhance suture repair of the ACL in skeletally immature animals: an in vivo study. J Orthop Res. 2009;27:639–45.
Oe K, Kushida T, Okamoto N, et al. New strategies for anterior cruciate ligament partial rupture using bone marrow transplantation in rats. Stem Cells Dev. 2011;20:671–9.
Pogorzelski J, Godin JA, Fritz EM, et al. The use of biological approaches in the treatment of shoulder pathology: a critical analysis review. JBJS Rev. 2017;e5:5.
Richmond JC, Weitzel PP. Bioresorbable scaffolds for anterior cruciate ligament reconstruction: do we need an off-the-shelf ACL substitute? Sports Med Arthrosc. 2010;18:40–2.
Silva A, Sampaio R, Fernandes R, et al. Is there a role for adult non-cultivated bone marrow stem cells in ACL reconstruction? Knee Surg Sports Traumatol Arthrosc. 2014;22:66–71.
Terada S, Ota S, Kobayashi M, et al. Use of an antifibrotic agent improves the effect of platelet-rich plasma on muscle healing after injury. J Bone Joint Surg Am. 2013;95:980–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 ISAKOS
About this chapter
Cite this chapter
Pogorzelski, J., Kennedy, M., LaPrade, R.F. (2019). Biologic Treatment of Ligament Injuries by the Sports Physician. In: Rocha Piedade, S., Imhoff, A., Clatworthy, M., Cohen, M., Espregueira-Mendes, J. (eds) The Sports Medicine Physician. Springer, Cham. https://doi.org/10.1007/978-3-030-10433-7_43
Download citation
DOI: https://doi.org/10.1007/978-3-030-10433-7_43
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-10432-0
Online ISBN: 978-3-030-10433-7
eBook Packages: MedicineMedicine (R0)